Telaprevir and ribavirin interaction: higher ribavirin levels are not only due to renal dysfunction during triple therapy.

about

Telaprevir and ribavirin interaction: higher ribavirin levels are not only due to renal dysfunction during triple therapy.

Item

http://www.wikidata.org/entity/Q35607785

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Telaprevir and ribavirin inter ...... unction during triple therapy.

@ast

Telaprevir and ribavirin inter ...... unction during triple therapy.

@en

type

Item

label

Telaprevir and ribavirin inter ...... unction during triple therapy.

@ast

Telaprevir and ribavirin inter ...... unction during triple therapy.

@en

prefLabel

Telaprevir and ribavirin inter ...... unction during triple therapy.

@ast

Telaprevir and ribavirin inter ...... unction during triple therapy.

@en

P1476

Telaprevir and ribavirin inter ...... function during triple therapy

@en

P2093

Almudena Torres-Cornejo

http://www.w3.org/2001/XMLSchema#string

Juan R Castillo-Ferrando

http://www.w3.org/2001/XMLSchema#string

Nuria Espinosa

http://www.w3.org/2001/XMLSchema#string

Omar J Ben-Marzouk-Hidalgo

http://www.w3.org/2001/XMLSchema#string

Pompeyo Viciana

http://www.w3.org/2001/XMLSchema#string

Rosa Ruiz-Valderas

http://www.w3.org/2001/XMLSchema#string

P2860

Early ribavirin pharmacokinetics, HCV RNA and alanine aminotransferase kinetics in HIV/HCV co-infected patients during treatment with pegylated interferon and ribavirin

The clinical pharmacology of ribavirin.

Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat

Telaprevir versus boceprevir in chronic hepatitis C: a meta-analysis of data from phase II and III trials.

Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C

Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions.

Pharmacokinetics of ribavirin in combined interferon-alpha 2b and ribavirin therapy for chronic hepatitis C virus infection

Entecavir for the treatment of chronic hepatitis B virus infection.

Virological response rates for telaprevir-based hepatitis C triple therapy in patients with and without HIV coinfection.

Mechanism of active renal tubular efflux of tenofovir.

P304

3257-3262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.04795-14

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Luis Fernando López-Cortés

Alicia Gutiérrez-Valencia

P577

2015-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25801562

http://www.w3.org/2001/XMLSchema#string

P932

4432178

http://www.w3.org/2001/XMLSchema#string